New requirements for medicine registration in the EU will improve global data exchange between pharmaceutical companies and regulatorsJune 14, 2021
Inpharmatis & Epista Partnership Announcement
We are delighted and proud to announce that Inpharmatis, a leading consulting company that provides full services for life science industry, signed a partnership agreement with Epista Life Science, a consultancy dedicated to continuously improving regulatory compliance.
Inpharmatis and Epista Life Science’s partnership allows us to introduce validation services to clients using an Automated Boost license in the CIS & Baltic regions. Automated Boost, a test automation tool specifically built for the GxP demands of the Life Science industry, ensures companies are ready for an audit or inspection, while they also increase quality and efficiency, and save time and money on the overall validation process. As an example, using Automated Boost in combination with an average size ERP system can save up to 250 working days within three years.
“Epista is filling a great need in the industry with this innovative solution. It will surely make the validation processes of many pharmaceutical companies more efficient and increase the overall quality. We are looking forward to a fruitful partnership,” said Dr.Polina Dombure, CEO at Inpharmatis.
“The Partnership with Inpharmatis is a perfect symbiosis of the two companies: - Inpharmatis knowing the CIS market, and customer and requirements in and out, and Epista being the expert for all validation and test automation topics. We are delighted to welcome Inpharmatis into our partner network,” said Christian Bohrmann, Managing Director of Epista Germany.
Inpharmatis is an international consulting company with headquarters in Riga, Latvia, and more than 15 years of proven experience in providing full services in regulatory affairs, pharmacovigilance, GMP, and GDP, as well as information technology solutions for the life science industry over the whole European & CIS market. Today, Inpharmatis is the only consulting company operating in the CIS region with full geographical coverage of all 15 countries, and only full-time multilingual employees on board.
Epista Life Science is a consultancy established in 2009. Today, Epista’s vision to eliminate regulatory compliance challenges for clients and to continuously improve regulatory compliance in the Life Sciences has been proven with over 150 global clients. Epista helps bridge the gap between IT, Quality, and Line-of-Business departments by building regulatory requirements seamlessly into business processes. This turns compliance obstacles into real business opportunities, intelligently aligning compliance across organizations, projects, and systems.
For additional information about validation services in the CIS & Baltics region, please contact us: firstname.lastname@example.org or +37167210500.
Новые требования к подаче сведений при регистрации лекарственных средств в Евросоюзе улучшат глобальный обмен данными между фармкомпаниями и регуляторамиJune 10, 2021
Inpharmatis принял участие в работе ПМЭФ-2021June 04, 2021
Ольга Звонарева возглавит в Inpharmatis направление Regulatory Affairs в России и странах СНГMay 31, 2021
Inpharmatis appoints new RA Director in Russia & CISMay 31, 2021
Приведение досье в соответствие с правилами ЕАЭСMay 27, 2021
Bringing the dossier in accordance with the rules of the EAEUMay 27, 2021
Inpharmatis и «АКАДЕМФАРМ» обсудили в Минске перспективы сотрудничестваMay 21, 2021
Inpharmatis and “ACADEMPHARM” discussed in Minsk cooperation opportunitiesMay 21, 2021
Participation in IPhEB Russia 2021April 19, 2021